Limitations of CD44v6 for Detecting Colorectal Cancer Cells in Blood
Author Information
Author(s): Masson D, Denis M G, Lustenberger P
Primary Institution: Laboratoire de Biochimie Spécialisée, Institut de Biologie, Nantes, France
Hypothesis
Can CD44v6 expression be used to detect and assess the metastatic potential of colorectal tumor cells in peripheral blood?
Conclusion
The study found that CD44v6 transcripts cannot effectively detect colorectal cancer micrometastases in blood samples.
Supporting Evidence
- Strong signals were detected in all healthy donor blood samples, indicating the method's ineffectiveness.
- 50% of gastrointestinal disease samples tested positive for CD44v6 transcripts.
- 85.7% of colorectal cancer samples that were cytokeratin 19-positive were CD44v6-negative.
Takeaway
The researchers tried to find cancer cells in blood using a special test, but it didn't work well.
Methodology
A nested RT-PCR assay was used on blood samples from patients with gastrointestinal disease and colorectal cancer.
Potential Biases
Potential bias due to the persistence of CD8+ leucocytes in enriched preparations.
Limitations
The method could not reliably detect colorectal carcinoma cells in whole blood.
Participant Demographics
12 patients with gastrointestinal disease and 10 patients with colorectal cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website